Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.Wensi Zhao, Ke‐Neng Chen, Dongbo Chen et al.|PubMed|2019Cited by 31